Blog | Page 4 of 14 | The Myositis Association

TMA expands Medical Advisory Board

September 25, 2018December 19, 2018

The Myositis Association announces the appointment of three new myositis experts to its Medical Advisory Board.

Treatment for dermatomyositis receives orphan designation

September 18, 2018January 16, 2019

Corbus Pharmaceuticals announced today that the European Union has approved orphan designation for lenabasum for the treatment of dermatomyositis.

Patients Gather to Learn About Myositis

August 28, 2018January 9, 2019

PRESS RELEASE August 28, 2018 In early 2015, Mike Matthews, a teacher, social worker, and counselor for the State of Kentucky, experienced a constellation of apparently unrelated health problems that doctors could not diagnose.

You may qualify for a research study

August 10, 2018January 4, 2019

Bristol-Myers Squibb is currently sponsoring a research study for patients with systemic lupus erythematosus (SLE). People diagnosed with lupus can sometimes also develop myositis, an inflammation of the skeletal muscles that causes weakness and loss of strength.

TMA Welcomes New Executive Director

August 7, 2018January 4, 2019

PRESS RELEASE August 7, 2018 The Myositis Association is pleased to announce the appointment of Mary McGowan as its Executive Director. McGowan takes over as current Executive Director Bob Goldberg retires following TMA’s Annual Patient Conference this September.